Cardiol Therapeutics Inc.
CRDL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$36,677 | -$28,128 | -$30,931 | -$31,638 |
| Dep. & Amort. | $373 | $248 | $220 | $220 |
| Deferred Tax | $0 | $0 | -$9,161 | -$4,916 |
| Stock-Based Comp. | $14,277 | $4,157 | $5,013 | $8,498 |
| Change in WC | -$932 | -$546 | $5,748 | $77 |
| Other Non-Cash | -$2,103 | -$911 | $1,890 | $4,209 |
| Operating Cash Flow | -$25,061 | -$25,180 | -$27,220 | -$23,551 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$21 | -$64 | -$75 | -$13 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$21 | -$64 | -$75 | -$13 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$42 | -$55 | -$54 | -$52 |
| Stock Issued | $21,356 | $0 | $0 | $84,084 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$2,474 | $0 | -$0 | $9,406 |
| Financing Cash Flow | $18,840 | -$55 | -$54 | $93,438 |
| Forex Effect | $1,890 | $762 | $2,920 | -$11 |
| Net Chg. in Cash | -$4,352 | -$24,538 | -$24,429 | $69,874 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $34,932 | $59,470 | $83,899 | $14,025 |
| End Cash | $30,580 | $34,932 | $59,470 | $83,899 |
| Free Cash Flow | -$25,082 | -$25,245 | -$27,295 | -$23,564 |